Vascular Closure Devices Market
Vascular Closure Devices Market Forecasts to 2030 - Global Analysis By Product (Passive Approximators, Active Approximators and External Haemostatic Devices), Access Mode (Femoral Access and Radial Access), Application (Peripheral Vascular Interventions, Cerebrovascular Interventions and Other Applications), End User and By Geography
According to Stratistics MRC, the Global Vascular Closure Devices Market is accounted for $1.3 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Vascular closure devices (VCDs) are medical instruments designed to seal or close punctures in blood vessels, typically following catheter-based procedures like angiography or percutaneous coronary interventions. These devices are crucial for minimizing bleeding, reducing complications, and expediting recovery by facilitating faster hemostasis at the puncture site. VCDs operate through various mechanisms, including mechanical compression, tissue adhesives, or the deployment of specialized plugs or patches. By effectively sealing the vascular entry point, VCDs help prevent complications such as hematomas, bleeding, or infections, and allow patients to resume normal activities more quickly.
According to the British Heart Foundation, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. According to the data by Centers for Medicare and Medicaid Services (CMS.gov) shows that in 2023, the U.S. spent approximately USD 4.7 trillion on healthcare, constituting 18% of the national economy.
Market Dynamics:
Driver:
Growing preference for minimally invasive procedures
The increasing preference for minimally invasive procedures is driving advancements in Vascular Closure Devices (VCDs), which are crucial for efficiently closing access sites after catheter-based interventions. As healthcare shifts towards less invasive techniques to reduce patient recovery times and minimize complications, VCDs are evolving to meet these demands. Modern VCDs offer improved safety, efficacy, and patient comfort by using advanced materials and technologies to ensure rapid and secure closure of vascular access points. This trend reflects a broader movement in medicine towards procedures that involve smaller incisions, less pain, and quicker returns to normal activities.
Restraint:
Clinical risks and complications
Vascular Closure Devices (VCDs) are designed to close femoral artery access sites after catheter-based procedures, aiming to minimize bleeding and expedite recovery. Their use carries clinical risks and complications that can impede their effectiveness. Key risks include infection, hematoma formation, and vascular injury, which can lead to complications like limb ischemia or thrombosis. There is also the potential for device-related issues such as inadequate sealing or device migration, which can cause bleeding or arterial damage.
Opportunity:
Rise in cardiovascular procedures
As the volume of procedures like angioplasty and stent placements rises, the demand for efficient, safe, and effective VCDs has surged. Modern VCDs are designed to provide faster hemostasis, reduce complications such as bleeding and infection, and shorten recovery times. Innovations in VCD technology include improved materials for better tissue sealing, enhanced ease of use for clinicians, and designs that accommodate various vascular access sites. These advancements not only facilitate quicker patient recovery but also enhance procedural efficiency, aligning with the growing complexity and frequency of cardiovascular interventions.
Threat:
Intellectual property challenges
The vascular closure device (VCD) industry faces significant challenges due to intellectual property (IP) issues. Patent disputes and restrictive IP claims can stifle innovation by preventing new entrants from developing or marketing their own devices. Established companies often hold broad patents that cover fundamental technologies, creating barriers for startups and other competitors. This situation can lead to expensive legal battles, which divert resources away from research and development. Stringent IP regulations can delay the introduction of new, potentially better devices to the market, limiting advancements in patient care. The result is a constrained market where innovation is slowed, and the cost of devices may remain high, impacting accessibility and treatment options for patients.
Covid-19 Impact:
The COVID-19 pandemic significantly impacted the vascular closure devices (VCDs) market due to disruptions in elective procedures and a shift in healthcare priorities. As hospitals worldwide focused on managing severe COVID-19 cases, many non-urgent procedures, including those requiring vascular access, were postponed or canceled. This led to a temporary decline in demand for VCDs, which are used to close the arterial access site after catheter-based procedures. Supply chain disruptions and restrictions affected the production and distribution of these devices. The pandemic also accelerated the adoption of remote and less invasive diagnostic techniques, further impacting the traditional usage of VCDs.
The Active Approximators segment is expected to be the largest during the forecast period
Active Approximators segment is expected to be the largest during the forecast period. Active approximators are revolutionizing vascular closure devices by significantly improving their efficacy and ease of use. These advanced devices utilize dynamic mechanisms to securely close the puncture site left after catheterization procedures. Unlike traditional passive methods that rely on static pressure or manual manipulation, active approximators apply controlled, adjustable forces to precisely align and seal the vascular opening. This innovation enhances the device's ability to achieve a reliable closure with minimal complications, such as bleeding or infection.
The Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period
Cerebrovascular Interventions segment is expected to have the highest CAGR during the forecast period. Cerebrovascular Interventions segment focus on increasing the precision of vascular closure, reducing complication rates, and shortening recovery times. Modern VCDs are designed with innovative features such as improved hemostatic agents and more adaptable closure mechanisms, which ensure better sealing of the access site and minimal trauma to surrounding tissues. Additionally, the incorporation of real-time imaging and advanced tracking systems allows for more accurate device placement and monitoring.
Region with largest share:
Europe region commanded the largest market share over the extrapolated period driven by the integration of cutting-edge technologies, improved medical training, and streamlined regulatory processes. Advanced VCDs, which are crucial for sealing arterial punctures after procedures like catheterizations, are benefiting from increased investment in healthcare facilities and research across the region. Enhanced infrastructure facilitates the development and deployment of innovative devices that offer greater precision, safety, and patient comfort throughout the region. Hospitals and clinics equipped with state-of-the-art tools and facilities can more effectively utilize these advanced VCDs, leading to improved procedural outcomes and reduced recovery times. These elements are boosting the regional growth.
Region with highest CAGR:
Europe region is projected to witness substantial growth during the forecast period due to the adoption of Vascular Closure Devices (VCDs) by ensuring stringent safety and efficacy standards. The European Union's regulatory framework, including the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), mandates rigorous clinical evaluations, quality control measures, and post-market surveillance for these devices. This regulatory oversight fosters innovation by encouraging manufacturers to adhere to high standards, thus driving advancements in technology and improving patient outcomes across the region.
Key players in the market
Some of the key players in Vascular Closure Devices market include Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc, Endologix, Inc, GE Healthcare, HeartWare International, Inc, Medtronic PLC, Nipro Corporation, Stryker Corporation and Terumo Corporation.
Key Developments:
In June 2024, Haemonetics Corporation has announced the launch of its new VASCADE MVP XL mid-bore venous closure device. The VASCADE MVP XL system adds to Haemonetics VASCADE line of vascular closure devices by using novel collapsible disc technology with a patented resorbable collagen patch that promotes fast hemostasis.
In November 2023, Johnson & Johnson Service Inc., a biotechnology company, announced the completion of the acquisition of Laminar, Inc., a privately held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).
In February 2023, the LockeT product was introduced to the market by Catheter Precision, Inc., a wholly-owned subsidiary of Ra Medical Systems, Inc. The first shipments of the product to its distributors will start right away. When a catheter is inserted through the skin into a blood artery and subsequently removed after an operation, LockeT can be utilized in combination with the closure of the percutaneous wound site.
Products Covered:
• Passive Approximators
• Active Approximators
• External Haemostatic Devices
Access Modes Covered:
• Femoral Access
• Radial Access
Applications Covered:
• Peripheral Vascular Interventions
• Cerebrovascular Interventions
• Other Applications
End Users Covered:
• Hospitals
• Cardiac Catheterization Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Vascular Closure Devices Market, By Product
5.1 Introduction
5.2 Passive Approximators
5.3 Active Approximators
5.4 External Haemostatic Devices
6 Global Vascular Closure Devices Market, By Access Mode
6.1 Introduction
6.2 Femoral Access
6.3 Radial Access
7 Global Vascular Closure Devices Market, By Application
7.1 Introduction
7.2 Peripheral Vascular Interventions
7.3 Cerebrovascular Interventions
7.4 Other Applications
8 Global Vascular Closure Devices Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Cardiac Catheterization Laboratories
8.4 Other End Users
9 Global Vascular Closure Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Abbott Laboratories
11.2 Boston Scientific Corporation
11.3 Cardinal Health, Inc
11.4 Endologix, Inc
11.5 GE Healthcare
11.6 HeartWare International, Inc
11.7 Medtronic PLC
11.8 Nipro Corporation
11.9 Stryker Corporation
11.10 Terumo Corporation
List of Tables
1 Global Vascular Closure Devices Market Outlook, By Region (2022-2030) ($MN)
2 Global Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
3 Global Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
4 Global Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
5 Global Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
6 Global Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
7 Global Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
8 Global Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
9 Global Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
10 Global Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
11 Global Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
12 Global Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
13 Global Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
14 Global Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
15 Global Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
16 Global Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
17 North America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
18 North America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
19 North America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
20 North America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
21 North America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
22 North America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
23 North America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
24 North America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
25 North America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
26 North America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
27 North America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
28 North America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
29 North America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
30 North America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
31 North America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
32 North America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
33 Europe Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
34 Europe Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
35 Europe Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
36 Europe Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
37 Europe Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
38 Europe Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
39 Europe Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
40 Europe Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
41 Europe Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
42 Europe Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
43 Europe Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
44 Europe Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
45 Europe Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
46 Europe Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
47 Europe Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
48 Europe Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
49 Asia Pacific Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
50 Asia Pacific Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
51 Asia Pacific Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
52 Asia Pacific Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
53 Asia Pacific Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
54 Asia Pacific Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
55 Asia Pacific Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
56 Asia Pacific Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
57 Asia Pacific Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
58 Asia Pacific Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
59 Asia Pacific Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
60 Asia Pacific Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
61 Asia Pacific Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
62 Asia Pacific Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
63 Asia Pacific Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
64 Asia Pacific Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
65 South America Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
66 South America Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
67 South America Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
68 South America Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
69 South America Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
70 South America Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
71 South America Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
72 South America Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
73 South America Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
74 South America Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
75 South America Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
76 South America Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
77 South America Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
78 South America Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
79 South America Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
80 South America Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
81 Middle East & Africa Vascular Closure Devices Market Outlook, By Country (2022-2030) ($MN)
82 Middle East & Africa Vascular Closure Devices Market Outlook, By Product (2022-2030) ($MN)
83 Middle East & Africa Vascular Closure Devices Market Outlook, By Passive Approximators (2022-2030) ($MN)
84 Middle East & Africa Vascular Closure Devices Market Outlook, By Active Approximators (2022-2030) ($MN)
85 Middle East & Africa Vascular Closure Devices Market Outlook, By External Haemostatic Devices (2022-2030) ($MN)
86 Middle East & Africa Vascular Closure Devices Market Outlook, By Access Mode (2022-2030) ($MN)
87 Middle East & Africa Vascular Closure Devices Market Outlook, By Femoral Access (2022-2030) ($MN)
88 Middle East & Africa Vascular Closure Devices Market Outlook, By Radial Access (2022-2030) ($MN)
89 Middle East & Africa Vascular Closure Devices Market Outlook, By Application (2022-2030) ($MN)
90 Middle East & Africa Vascular Closure Devices Market Outlook, By Peripheral Vascular Interventions (2022-2030) ($MN)
91 Middle East & Africa Vascular Closure Devices Market Outlook, By Cerebrovascular Interventions (2022-2030) ($MN)
92 Middle East & Africa Vascular Closure Devices Market Outlook, By Other Applications (2022-2030) ($MN)
93 Middle East & Africa Vascular Closure Devices Market Outlook, By End User (2022-2030) ($MN)
94 Middle East & Africa Vascular Closure Devices Market Outlook, By Hospitals (2022-2030) ($MN)
95 Middle East & Africa Vascular Closure Devices Market Outlook, By Cardiac Catheterization Laboratories (2022-2030) ($MN)
96 Middle East & Africa Vascular Closure Devices Market Outlook, By Other End Users (2022-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
